Turcot V, Lu Y, Highland HM, Schurmann C, Justice AE, Fine RS, Bradfield JP, Esko T, Giri A, Graff M Tuomilehto J. et al. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet. 2018;50(1):26-41.
Turcot V, Lu Y, Highland HM, Schurmann C, Justice AE, Fine RS, Bradfield JP, Esko T, Giri A, Graff M Tuomilehto J. et al.
2018
January
Nat Genet.
27.125
Prof. Jaakko Tuomilehto
Al Madhoun A, Alkandari S, Ali H, Carrio N, Atari M, Bitar MS, Al-Mulla F. Chemically Defined Conditions Mediate an Efficient Induction of Mesodermal Lineage from Human Umbilical Cord- and Bone Marrow- Mesenchymal Stem Cells and Dental Pulp Pluripotent-Like Stem Cells. Cell Reprogram. 2018;20(1):9-16
Al Madhoun A, Alkandari S, Ali H, Carrio N, Atari M, Bitar MS, Al-Mulla F.
2018
February
Cell Reprogram
1.430
Genetics and BioInformatics
Al-Serri A, Al-Bustan S.A, Kamkar M, Thomas D, Al-Smaidi O, Al-Temaimi R, Mojiminiyi O.A, Abdella N. Association of FTO rs9939609 with Obesity in The Kuwaiti Population: A Public Health Concern?. Med Princ Pract. 2018; doi: 10.1159/000486767.
Al-Serri A, Al-Bustan S.A, Kamkar M, Thomas D, Al-Smaidi O, Al-Temaimi R, Mojiminiyi O.A, Abdella N
2018
February
Med Princ Pract.
1.536
Genetics and BioInformatics
Bertoli-Avella AM, Garcia-Aznar JM, Al-Mulla F, Rolfs Abauer P. Biallelic inactivating variants in the GTPBP2 gene cause a neurodevelopmental disorder with severe intellectual disability. Online First: Eur J Hum Genet. 2018; doi:10.1038/s41431-018-0097-3
Bertoli-Avella AM, Garcia-Aznar JM, Al-Mulla F, Rolfs Abauer P
2018
February
Eur J Hum Genet.
3.636
Genetics and BioInformatics
Dahlqvist S, Ahlen E, Filipsson K, Gustafsson T, Hirsch IB, Tuomilehto J, Imberg H, Ahren B, Attvall S, Lind M. Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3). BMJ Open Diabetes Res Care. 2018;6(1):e000464.
Dahlqvist S, Ahlen E, Filipsson K, Gustafsson T, Hirsch IB, Tuomilehto J, Imberg H, Ahren B, Attvall S, Lind M.
2018
February
BMJ Open Diabetes Res Care
N/A
Prof. Jaakko Tuomilehto
Gilis-Januszewska A, Lindstrom J, Barengo NC, Tuomilehto J, Schwarz PE, Wojtowicz E, Piwonska-Solska B, Szybinski Z, Windak A, Hubalewska-Dydejczyk A. Predictors of completing a primary health care diabetes prevention intervention programme in people at high risk of type 2 diabetes: Experiences of the DE-PLAN project. Medicine (Baltimore). 2018;97(5):e9790
Gilis-Januszewska A, Lindstrom J, Barengo NC, Tuomilehto J, Schwarz PE, Wojtowicz E, Piwonska-Solska B, Szybinski Z, Windak A, Hubalewska-Dydejczyk A.
2018
February
Medicine
2.028
Prof. Jaakko Tuomilehto
Abu-Farha M, Cherian P, Qaddoumi MG, AlKhairi I, Sriraman D, Alanbaei M, Abubaker J. Increased plasma and adipose tissue levels of ANGPTL8/Betatrophin and ANGPTL4 in people with hypertension. Lipids Health Dis. 2018;17(1):35
Abu-Farha M, Cherian P, Qaddoumi MG, AlKhairi I, Sriraman D, Alanbaei M, Abubaker J.
2018
March
Lipids Health Dis.
2.663
Biochemistry and Molecular Biology
Acosta T, Barengo N, Arrieta A, Ricaurte C, Tuomilehto J. A demonstration area for type 2 diabetes prevention in Barranquilla and Juan Mina (Colombia) Baseline characteristics of the study participants. Medicine. 2018; 97:1(e9285)
Acosta T, Barengo N, Arrieta A, Ricaurte C, Tuomilehto J
2018
January
Medicine
2.028
Prof. Jaakko Tuomilehto
Ali F, Alsayegh F, Sharma P, Waheedi M, Bayoud T, Alrefai F. White blood cell subpopulation changes and prevalence of neutropenia among Arab diabetic patients attending Dasman Diabetes Institute in Kuwait. PLoS One. 2018;13(3):e0193920.
Ali F, Alsayegh F, Sharma P, Waheedi M, Bayoud T, Alrefai F.
2018
March
PLoS One
2.766
COO; Special Services Facility
Brainin M, Feigin V, Martins S, Matz K, Roy J, Sandercock P, Teuschl Y, Tuomilehto J, Wiseman A. Cut stroke in half: Polypill for primary prevention in stroke. Int J Stroke. 2018;1:1747493018761190.
Brainin M, Feigin V, Martins S, Matz K, Roy J, Sandercock P, Teuschl Y, Tuomilehto J, Wiseman A.
2018
January
Int J Stroke
3.859
Prof. Jaakko Tuomilehto
Cornelis MC, Erlund I, Michelotti GA, Herder C, Westerhuis JA, Tuomilehto J. Metabolomic response to coffee consumption: application to a three-stage clinical trial. Early view: J Intern Med. 2018; doi.org/10.1111/joim.12737
Cornelis MC, Erlund I, Michelotti GA, Herder C, Westerhuis JA, Tuomilehto J.
2018
March
J Intern Med.
6.754
Prof. Jaakko Tuomilehto
Khadir A, Kavalakatt S, Cherian P, Warsame S, Abubaker J, Dehbi M, Tiss A. Physical Exercise Enhanced Heat Shock Protein 60 Expression and Attenuated Inflammation in the Adipose Tissue of Human Diabetic Obese. Front Endocrinol. 2018; 9(16)
Khadir A, Kavalakatt S, Cherian P, Warsame S, Abubaker J, Dehbi M, Tiss A.
2018
January
Front Endocrinol.
3.519
Biochemistry and Molecular Biology; Genetics & Bioinformatics
Liu H, Wang L, Zhang S, Leng J, Li N, Li W, Wang J, Tian H, Qi L, Yang X, Yu Z, Tuomilehto J, Hu G. One-year weight losses in the Tianjin Gestational Diabetes Mellitus Prevention Program: A Randomized Clinical Trial. Early View: Diabetes Obes Metab. 2018;20(5):1246-1255.
Liu H, Wang L, Zhang S, Leng J, Li N, Li W, Wang J, Tian H, Qi L, Yang X, Yu Z, Tuomilehto J, Hu G
2018
January
Diabetes Obes Metab.
5.980
Prof. Jaakko Tuomilehto
Madhu D, Hammad M, Kavalakatt S, Khadir A, Tiss A. GLP-1 analogue, Exendin-4, modulates MAPKs activity but not the heat shock response in human HepG2 cells. Proteomics Clin. Appl. 2018; 12 (1),1600169
Madhu D, Kavalakatt S, Khadir A, Tiss A
2018
January
Proteomics Clin. Appl
3.567
Biochemistry and Molecular Biology
Mezzavilla M, Tomei S, Alkayal F, Melhem M, Ali MM, Al-Arouj M, Bennakhi A, Alsmadi O, Elkum N. Investigation of genetic variation and lifestyle determinants in vitamin D levels in Arab individuals. J Transl Med. 2018;16(1):20.
Mezzavilla M, Tomei S, Alkayal F, Melhem M, Ali MM, Al-Arouj M, Bennakhi A, Alsmadi O, Elkum N.
2018
January
J Transl Med.
4.197
Genetics and BioInformatics; Clinical Trials